✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

argenx SE

Common Name
argenx
Country
Netherlands
Sector
Healthcare
Industry
Biotechnology
Employees
1,599
Ticker
ARGX
Exchange
EURONEXT
Description
argenx SE is a commercial-stage, global, fully-integrated biopharmaceutical company headquartered in Amsterdam, Netherlands, specializing in the development of differentiated antibody-based therapies ...

argenx's Financial Statements Preview

Below are the financial statements of argenx, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Product net sales
2,185.88a
1,190.78a
400.72a
Collaboration revenue
4.35a
35.53a
10.03a
Other operating income
61.81a
42.28a
34.52a
Total operating income
2,252.04a
1,268.59a
445.27a
Cost of sales
-227.29a
-117.84a
-29.43a
Research and development expenses
-983.42a
-859.49a
-663.37a
Selling, general and administrative expenses
-1,055.34a
-711.91a
-472.13a
Loss from investment in a joint venture
-7.64a
-4.41a
-0.68a
Total operating expenses
-2,273.69a
-1,693.64a
-1,165.61a
Operating loss
-21.65a
-425.05a
-720.34a
Financial income
157.51a
107.39a
27.67a
Financial expense
-2.46a
-0.91a
-3.91a
Exchange (losses)/gains
-48.21a
14.07a
-32.73a
Profit/(loss) for the year before taxes
85.18a
-304.5a
-729.31a
Income tax benefit
747.86a
9.44a
19.72a
Profit/(loss) for the year
833.04a
-295.05a
-709.59a
Profit/(loss) for the year attributable to: owners of the parent
833.04a
-295.05a
-709.59a
Limited Data Preview
You are viewing a limited preview of argenx’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind argenx’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore argenx’s data sources below and access millions more through our Disclosure Search.

a. argenx's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?